Cyban Pty Ltd is an Australian technology company focused on developing a novel, non-invasive continuous tissue oxygen monitor. Initial commercialisation focus is on measuring cerebral (brain oxygen) in intensive care and emergency departments. Cyban was formed from research led by Dr. Barry Dixon, an Intensive Care Clinician. Dr. Dixon recognised that a major clinical challenge exists for patients with severe traumatic brain injury in that current monitoring systems have significant limitations. Consequently, detection and treatment of tissue hypoxia is often delayed, resulting in a worse injury to the patient. Cyban’s technology aims to reduce or eliminate secondary injuries due to hypoxia by allowing early detection and more importantly intervention for a better patient outcome.